Overview

Subtypes of Provoked Vestibulodynia

Status:
Active, not recruiting
Trial end date:
2021-08-01
Target enrollment:
0
Participant gender:
Female
Summary
The proposed study will evaluate a clinical algorithm for the diagnosis and treatment of provoked vestibulodynia (PVD). The algorithm, distinguishes between four subtypes of PVD: hormonally mediated PVD, hypertonic pelvic floor dysfunction, congenital neuroproliferative PVD and acquired neuroproliferative PVD, based on a patient's history and physical exam. The study will follow patients diagnosed with PVD, for one year, and evaluate the treatment outcome in the different subgroups. Investigators hope that conducting a prospective study, showing clinical benefit and improved outcome for patients classified according to this method may change the common practice of "trial and error" based treatment, and will improve clinical results.
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Meir Medical Center
Treatments:
Estrogens
Criteria
Inclusion Criteria:

1. A history of 3 months or more of vulvar pain suggestive of PVD, i.e. symptoms of pain
on vaginal penetration (insertional dyspareunia and/or pain with tampon insertion).

2. On exam, tenderness localized within the vestibule when being touched with a
cotton-tip applicator.

3. No identifiable cause for the pain, such as vulvovaginal candidiasis, vaginal atrophy,
desquamative inflammatory vaginitis (DIV), herpes, dermatitis or vulvar dystrophy.

Exclusion criteria:

1. other causes for vulvar pain

2. pregnancy or a planned pregnancy in the upcoming year

3. unprovoked or mixed vulvodynia.